Marinus A J Borgdorff1, Anne Marie C Koop2, Vincent W Bloks3, Michael G Dickinson2, Paul Steendijk4, Herman H W Sillje5, Maarten P H van Wiechen2, Rolf M F Berger2, Beatrijs Bartelds2. 1. Center for Congenital Heart Diseases, Department of Pediatric Cardiology, Beatrix Children's Hospital, The Netherlands; Cardiovascular Center-laboratory for Experimental Cardiology, Graduate School of Medical Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: m.a.j.borgdorff@umcg.nl. 2. Center for Congenital Heart Diseases, Department of Pediatric Cardiology, Beatrix Children's Hospital, The Netherlands; Cardiovascular Center-laboratory for Experimental Cardiology, Graduate School of Medical Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. 3. University of Groningen, University Medical Center Groningen, Laboratory of Pediatrics, Center for Liver, Digestive, and Metabolic Diseases, Beatrix Children's Hospital, Groningen, The Netherlands. 4. Leiden University Medical Center, Department of Cardiology, Leiden, The Netherlands. 5. Cardiovascular Center-laboratory for Experimental Cardiology, Graduate School of Medical Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Abstract
BACKGROUND: Right ventricular failure (RVF) due to pressure load is a major cause of death in congenital heart diseases and pulmonary hypertension. The mechanisms of RVF are unknown. We used an experimental approach based upon clinical signs of RVF to delineate functional and biological processes associated with RVF. METHODS AND RESULTS: Wistar rats were subjected to a pulmonary artery banding (PAB n=12) or sham surgery (CON, n=7). After 52±5days, 5/12 PAB rats developed clinical symptoms of RVF (inactivity, ruffled fur, dyspnea, ascites) necessitating termination (PAB+CF). We compared these to PAB rats with RVF without clinical symptoms (PAB-). PAB resulted in reduced cardiac output, RV stroke volume, TAPSE, and increased end diastolic pressure (all p<0.05 vs. CON) in all rats, but PAB+CF rats were significantly more affected than PAB-, despite similar pressure load (p=ns). Pressure-volume analysis showed enhanced contractility (end systolic elastance) in PAB- and PAB+CF, but diastolic function (end diastolic elastance, end diastolic pressure) deteriorated especially in PAB+CF. In PAB+CF capillary density was lower than in PAB-. Gene-array analysis revealed downregulation of both fatty acid oxidation and carbohydrate metabolism in PAB+CF. CONCLUSION: Chronic PAB led to different degrees of RVF, with half of the rats developing severe clinical symptoms of RVF, associated with progressive deterioration of diastolic function, hypoxia-prone myocardium, increased response to oxidative stress and suppressed myocardial metabolism. This model represents clinical RVF and allows for unraveling of mechanisms involved in the progression from RV adaptation to RV failure and the effect of intervention on these mechanisms.
BACKGROUND:Right ventricular failure (RVF) due to pressure load is a major cause of death in congenital heart diseases and pulmonary hypertension. The mechanisms of RVF are unknown. We used an experimental approach based upon clinical signs of RVF to delineate functional and biological processes associated with RVF. METHODS AND RESULTS:Wistar rats were subjected to a pulmonary artery banding (PAB n=12) or sham surgery (CON, n=7). After 52±5days, 5/12 PABrats developed clinical symptoms of RVF (inactivity, ruffled fur, dyspnea, ascites) necessitating termination (PAB+CF). We compared these to PABrats with RVF without clinical symptoms (PAB-). PAB resulted in reduced cardiac output, RV stroke volume, TAPSE, and increased end diastolic pressure (all p<0.05 vs. CON) in all rats, but PAB+CF rats were significantly more affected than PAB-, despite similar pressure load (p=ns). Pressure-volume analysis showed enhanced contractility (end systolic elastance) in PAB- and PAB+CF, but diastolic function (end diastolic elastance, end diastolic pressure) deteriorated especially in PAB+CF. In PAB+CF capillary density was lower than in PAB-. Gene-array analysis revealed downregulation of both fatty acid oxidation and carbohydrate metabolism in PAB+CF. CONCLUSION: Chronic PAB led to different degrees of RVF, with half of the rats developing severe clinical symptoms of RVF, associated with progressive deterioration of diastolic function, hypoxia-prone myocardium, increased response to oxidative stress and suppressed myocardial metabolism. This model represents clinical RVF and allows for unraveling of mechanisms involved in the progression from RV adaptation to RV failure and the effect of intervention on these mechanisms.
Authors: Tik-Chee Cheng; Jennifer L Philip; Diana M Tabima; Timothy A Hacker; Naomi C Chesler Journal: Am J Physiol Heart Circ Physiol Date: 2018-06-08 Impact factor: 4.733
Authors: Tik-Chee Cheng; Diana M Tabima; Laura R Caggiano; Andrea L Frump; Timothy A Hacker; Jens C Eickhoff; Tim Lahm; Naomi C Chesler Journal: J Appl Physiol (1985) Date: 2022-02-03
Authors: Mei Sun; Ryo Ishii; Kenichi Okumura; Adrienn Krauszman; Siegfried Breitling; Olga Gomez; Aleksander Hinek; Stellar Boo; Boris Hinz; Kim A Connelly; Wolfgang M Kuebler; Mark K Friedberg Journal: J Am Heart Assoc Date: 2018-03-29 Impact factor: 5.501
Authors: Quint A J Hagdorn; Kondababu Kurakula; Anne-Marie C Koop; Guido P L Bossers; Emmanouil Mavrogiannis; Tom van Leusden; Diederik E van der Feen; Rudolf A de Boer; Marie-José T H Goumans; Rolf M F Berger Journal: Front Physiol Date: 2021-02-26 Impact factor: 4.566
Authors: Sae Jang; Rebecca R Vanderpool; Reza Avazmohammadi; Eugene Lapshin; Timothy N Bachman; Michael Sacks; Marc A Simon Journal: J Am Heart Assoc Date: 2017-09-12 Impact factor: 5.501
Authors: Horacio Márquez-González; Mario H Vargas; Lucelli Yáñez-Gutiérrez; Eduardo Almeida-Gutiérrez; Juan Garduño-Espinosa Journal: Front Pediatr Date: 2018-06-26 Impact factor: 3.418
Authors: Anne-Marie C Koop; Guido P L Bossers; Mark-Jan Ploegstra; Quint A J Hagdorn; Rolf M F Berger; Herman H W Silljé; Beatrijs Bartelds Journal: J Am Heart Assoc Date: 2019-10-28 Impact factor: 5.501